{
    "id": 3345,
    "fullName": "FLT3 D835E",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FLT3 D835E lies within the activation loop in the protein kinase domain of the Flt3 protein (PMID: 25837374). D835E results in constitutive phosphorylation of Flt3 and activation of Stat5, Erk signaling, leading to transformation of cultured cells (PMID: 15256420).",
            "references": [
                {
                    "id": 2706,
                    "pubMedId": 15256420,
                    "title": "Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15256420"
                },
                {
                    "id": 14183,
                    "pubMedId": 25837374,
                    "title": "Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25837374"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2322,
        "geneSymbol": "FLT3",
        "terms": [
            "FLT3",
            "CD135",
            "FLK-2",
            "FLK2",
            "STK1"
        ]
    },
    "variant": "D835E",
    "createDate": "02/25/2015",
    "updateDate": "09/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 144446,
        "transcript": "NM_004119",
        "gDna": "chr13:g.28018503A>C",
        "cDna": "c.2505T>G",
        "protein": "p.D835E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4809,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing FLT3-ITD along with FLT3 D835E were resistant to PLX3397 in culture (PMID: 25847190).",
            "molecularProfile": {
                "id": 19277,
                "profileName": "FLT3 exon 14 ins FLT3 D835E"
            },
            "therapy": {
                "id": 874,
                "therapyName": "Pexidartinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3027,
                    "pubMedId": 25847190,
                    "title": "Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 \"Gatekeeper\" F691L Mutation with PLX3397.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25847190"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4810,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing FLT3 ITD with R834Q and F691L were resistant to PLX3397 in culture (PMID: 25847190).",
            "molecularProfile": {
                "id": 19278,
                "profileName": "FLT3 exon 14 ins FLT3 F691L FLT3 D835E"
            },
            "therapy": {
                "id": 874,
                "therapyName": "Pexidartinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3027,
                    "pubMedId": 25847190,
                    "title": "Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 \"Gatekeeper\" F691L Mutation with PLX3397.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25847190"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3156,
            "profileName": "FLT3 D835E",
            "profileTreatmentApproaches": [
                {
                    "id": 3999,
                    "name": "FLT3 Inhibitor",
                    "profileName": "FLT3 D835E"
                }
            ]
        },
        {
            "id": 19277,
            "profileName": "FLT3 exon 14 ins FLT3 D835E",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 19278,
            "profileName": "FLT3 exon 14 ins FLT3 F691L FLT3 D835E",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144446,
            "transcript": "NM_004119",
            "gDna": "chr13:g.28018503A>C",
            "cDna": "c.2505T>G",
            "protein": "p.D835E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}